We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
DHI Group
DHX
$173M
| $1.39M | ﹤0.01% |
255,750
+73,597
| +40% | +$385K |
|
|
TVRD
2552
Tvardi Therapeutics
TVRD
$23.4M
| $1.39M | ﹤0.01% |
4,112
-312
| -7% | -$113K |
|
2553
PMV Pharmaceuticals
PMVP
$63.5M
| $1.39M | ﹤0.01% |
116,411
-588
| -0.5% | -$8.49K |
|
|
TPIC
2554
DELISTED
TPI Composites
TPIC
| $1.38M | ﹤0.01% |
122,620
-2,190
| -2% | -$34.6K |
|
2555
Southern Missouri Bancorp
SMBC
$850M
| $1.38M | ﹤0.01% |
27,091
-739
| -3% | -$37.8K |
|
2556
FRP Holdings
FRPH
$421M
| $1.38M | ﹤0.01% |
50,758
-1,314
| -3% | -$38.3K |
|
2557
DXP Enterprises
DXPE
$2.98B
| $1.38M | ﹤0.01% |
58,218
-920
| -2% | -$26.4K |
|
2558
Inspired Entertainment
INSE
$175M
| $1.38M | ﹤0.01% |
156,072
+51,474
| +49% | +$531K |
|
2559
Cullinan Oncology
CGEM
$1.14B
| $1.38M | ﹤0.01% |
107,360
+1,347
| +1% | +$18.1K |
|
2560
SmartFinancial
SMBK
$888M
| $1.38M | ﹤0.01% |
55,678
-1,294
| -2% | -$32.7K |
|
2561
Waterstone Financial
WSBF
$375M
| $1.38M | ﹤0.01% |
85,122
-2,166
| -2% | -$38.1K |
|
2562
Arrow Financial
AROW
$652M
| $1.37M | ﹤0.01% |
49,033
-1,318
| -3% | -$40.8K |
|
2563
El Pollo Loco
LOCO
$462M
| $1.36M | ﹤0.01% |
152,869
-290
| -0.2% | -$2.73K |
|
2564
Haverty Furniture Companies
HVT
$454M
| $1.36M | ﹤0.01% |
54,715
-2,897
| -5% | -$78.5K |
|
|
CTO
2565
CTO Realty Growth
CTO
$815M
| $1.36M | ﹤0.01% |
72,526
+26,560
| +58% | +$554K |
|
2566
Carter Bankshares
CARE
$731M
| $1.36M | ﹤0.01% |
84,289
-2,840
| -3% | -$44.4K |
|
|
SRDX
2567
DELISTED
Surmodics
SRDX
| $1.36M | ﹤0.01% |
44,621
-365
| -0.8% | -$12.5K |
|
2568
8x8 Inc
EGHT
$332M
| $1.36M | ﹤0.01% |
393,096
-2,197
| -0.6% | -$10.5K |
|
2569
RBB Bancorp
RBB
$455M
| $1.35M | ﹤0.01% |
65,181
-687
| -1% | -$14.9K |
|
2570
Johnson Outdoors
JOUT
$505M
| $1.35M | ﹤0.01% |
26,241
-435
| -2% | -$27.2K |
|
2571
ImmunityBio
IBRX
$8.1B
| $1.34M | ﹤0.01% |
269,983
-3,855
| -1% | -$17.6K |
|
2572
HF Foods Group
HFFG
$83.4M
| $1.34M | ﹤0.01% |
346,167
-2,385
| -0.7% | -$11.8K |
|
2573
Covenant Logistics
CVLG
$872M
| $1.34M | ﹤0.01% |
93,314
-7,728
| -8% | -$115K |
|
2574
IDT Corp
IDT
$1.62B
| $1.33M | ﹤0.01% |
53,595
-695
| -1% | -$17.9K |
|
|
OLP
2575
One Liberty Properties
OLP
$527M
| $1.33M | ﹤0.01% |
63,294
-905
| -1% | -$22.9K |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.